EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases

Lixin Du, Yifei Xiao, Qidong Wei, Zhihua Guo, Ya Li iD

Molecules · 18.09.2024 · 29 (18) · 4425

DOI: 10.3390/molecules29184425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 18.09.2024. Verfasst von Lixin Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Ginsenosides, Nanoparticles, Cardiovascular Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine, Postgraduate Scientific Research Innovation Project of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Objective

To optimize the preparation process of hyaluronic acid-modified ginsenoside Rb1 self-assembled nanoparticles (HA@GRb1@CS NPs), characterize and evaluate them in vitro, and investigate the mechanism of action of HA@GRb1@CS NPs in treating cardiovascular diseases (CVDs) associated with inflammation and oxidative stress. (2)

Methods

The optimal preparation process was screened through Plackett–Burman and Box–Behnken designs. Physical characterization of HA@GRb1@CS NPs was conducted using transmission electron microscopy, Fourier-transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry. Stability experiments, in vitro drug release studies, and lyophilisate selection were performed to evaluate the in vitro performance of HA@GRb1@CS NPs. The anti-inflammatory and antioxidant capabilities of HA@GRb1@CS NPs were assessed using H9c2 and RAW264.7 cells. Additionally, bioinformatics tools were employed to explore the mechanism of action of HA@GRb1@CS NPs in the treatment of CVDs associated with inflammation and oxidative stress. (3)

Results

The optimal preparation process for HA@GRb1@CS NPs was achieved with a CS concentration of 2 mg/mL, a TPP concentration of 2.3 mg/mL, and a CS to TPP mass concentration ratio of 1.5:1, resulting in a particle size of 126.4 nm, a zeta potential of 36.8 mV, and a PDI of 0.243. Characterization studies confirmed successful encapsulation of the drug within the carrier, indicating successful preparation of HA@GRb1@CS NPs. In vitro evaluations demonstrated that HA@GRb1@CS NPs exhibited sustained-release effects, leading to reduced MDA (Malondialdehyde) content and increased SOD (Superoxide Dismutase) content in oxidatively damaged H9c2 cells. Furthermore, it showed enhanced DPPH (2,2-Diphenyl-1-picrylhydrazyl) and ABTS+ [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)] free radical scavenging rates and inhibited the release of inflammatory factors NO (Nitric Oxide) and IL-6 (Interleukin-6) from RAW264.7 cells. (4)

Conclusions

The HA@GRb1@CS NPs prepared in this study exhibit favorable properties with stable quality and significant anti-inflammatory and antioxidant capabilities. The mechanisms underlying their therapeutic effects on CVDs may involve targeting STAT3, JUN, EGFR, CASP3, and other pathways regulating cell apoptosis, autophagy, anti-lipid, and arterial sclerosis signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidGinsenosidesNanoparticlesCardiovascular DiseasesAntioxidantsAnimalsMiceRAW 264.7 CellsComputational BiologyAnti-Inflammatory AgentsOxidative StressDrug LiberationCell LineRatsCell SurvivalDrug Carriers

Stichwörter der Autor:innen

bioinformaticscardiovascular diseasesginsenoside Rb1inflammationoxidative stressself-assembled nanoparticles

Substanzen

Hyaluronic AcidGinsenosidesginsenoside Rb1AntioxidantsAnti-Inflammatory AgentsDrug Carriers

Autor:innen und Institutionen

  • School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
  • School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.

ORCID-Profile: Ya Li

Förderung

  • National Natural Science Foundation of China
  • Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine
  • Postgraduate Scientific Research Innovation Project of Hunan Province
  • Hunan University students innovation and entrepreneurship training program
  • Scientific Research Topics of Hunan Provincial Health and Wellness Commission
  • Hunan University of Chinese Medicine 2023 Provincial Undergraduate Innovation and Entrepreneurship Training Program Project
  • Hunan Province Key Research Project in Traditional Chinese Medicine

Zitieren

APA

Du, L., Xiao, Y., Wei, Q., Guo, Z., & Li, Y. (2024). Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases. Molecules, 29(18), 4425. https://doi.org/10.3390/molecules29184425

Vancouver

Du L, Xiao Y, Wei Q, Guo Z, Li Y. Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases. Molecules. 2024;29(18):4425. doi:10.3390/molecules29184425

BibTeX
@article{Du2024,
  author = {Du, Lixin and Xiao, Yifei and Wei, Qidong and Guo, Zhihua and Li, Ya},
  title = {Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {18},
  pages = {4425},
  doi = {10.3390/molecules29184425}
}
Kostenlos starten →